Disappearance of double minute chromosomes with MYC amplification in relapsed acute myeloid leukemia after stem cell transplantation. 2015

Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan, kyamamo@med.kobe-u.ac.jp.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D002875 Chromosomes In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromosome
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D016259 Genes, myc Family of retrovirus-associated DNA sequences (myc) originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc (c-myc) codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8. L-myc Genes,N-myc Genes,c-myc Genes,myc Genes,v-myc Genes,L-myc Proto-Oncogenes,N-myc Proto-Oncogenes,c-myc Proto-Oncogenes,myc Oncogene,v-myc Oncogenes,Gene, L-myc,Gene, N-myc,Gene, c-myc,Gene, myc,Gene, v-myc,Genes, L-myc,Genes, N-myc,Genes, c-myc,Genes, v-myc,L myc Genes,L myc Proto Oncogenes,L-myc Gene,L-myc Proto-Oncogene,N myc Genes,N myc Proto Oncogenes,N-myc Gene,N-myc Proto-Oncogene,Oncogene, myc,Oncogene, v-myc,Oncogenes, myc,Oncogenes, v-myc,Proto-Oncogene, L-myc,Proto-Oncogene, N-myc,Proto-Oncogene, c-myc,Proto-Oncogenes, L-myc,Proto-Oncogenes, N-myc,Proto-Oncogenes, c-myc,c myc Genes,c myc Proto Oncogenes,c-myc Gene,c-myc Proto-Oncogene,myc Gene,myc Oncogenes,v myc Genes,v myc Oncogenes,v-myc Gene,v-myc Oncogene
D059785 Karyotype The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed) Karyotypes
D033581 Stem Cell Transplantation The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types. Transplantation, Stem Cell,Stem Cell Transplantations,Transplantations, Stem Cell

Related Publications

Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
March 1999, Cancer genetics and cytogenetics,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
January 2004, Annales de genetique,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
January 1996, Hematopathology and molecular hematology,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
November 1985, Lancet (London, England),
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
October 2017, International journal of hematology,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
July 1999, Cancer genetics and cytogenetics,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
January 2016, Cancer genetics,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
July 2000, Leukemia,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
January 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Katsuya Yamamoto, and Kimikazu Yakushijin, and Keiji Kurata, and Yukinari Sanada, and Shinichiro Kawamoto, and Hiroshi Matsuoka, and Hironobu Minami
April 2013, Annals of hematology,
Copied contents to your clipboard!